Get started
Author

Shirong Peng

The metastatic promoter DEPDC1B induces epithelial‐mesenchymal transition and promotes prostate cancer cell proliferation via Rac1‐PAK1 signaling
2020 · Zean Li, Qiong Wang, et al. · Clinical and Translational Medicine · 55
Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
2021 · Qiong Wang, Zean Li, et al. · Cancer Biology and Medicine · 40
PDF
B7 score and T cell infiltration stratify immune status in prostate cancer
2021 · Qianghua Zhou, Kaiwen Li, et al. · Journal for ImmunoTherapy of Cancer · 40
PDF
GADD45B Is a Potential Diagnostic and Therapeutic Target Gene in Chemotherapy-Resistant Prostate Cancer
2021 · Qiong Wang, Wanhua Wu, et al. · Frontiers in Cell and Developmental Biology · 39
PDF
Cancer-associated fibroblasts regulate mitochondrial metabolism and inhibit chemosensitivity via ANGPTL4-IQGAP1 axis in prostate cancer
2024 · Zhi Xiong, Rui-Lin Zhuang, et al. · Journal of Advanced Research · 36
Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer
2024 · Bingheng Li, Bisheng Cheng, et al. · International Journal of Biological Sciences · 35
Cancer-associated fibroblasts promote enzalutamide resistance and PD-L1 expression in prostate cancer through CCL5-CCR5 paracrine axis
2024 · Zhi Xiong, Shun-Li Yu, et al. · iScience · 27
Immune Cytolytic Activity as an Indicator of Immune Checkpoint Inhibitors Treatment for Prostate Cancer
2020 · Ze Gao, Yiran Tao, et al. · Frontiers in Bioengineering and Biotechnology · 23
PDF
MT1G , an emerging ferroptosis‐related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer
2023 · Bisheng Cheng, Yiming Lai, et al. · Environmental Toxicology · 22
SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion
2023 · Zean Li, Yiran Tao, et al. · Journal of Translational Medicine · 16
PDF
Glutathione-sensitive nanoparticles enhance the combined therapeutic effect of checkpoint kinase 1 inhibitor and cisplatin in prostate cancer
2022 · Shirong Peng, Xinyu Zhang, et al. · APL Bioengineering · 13
Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression
2023 · Zhi Xiong, Tong Tong, et al. · Biomaterials Science · 11
An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer
2025 · Ruilin Zhuang, Ruihui Xie, et al. · Journal of Translational Medicine · 10
PDF
Inflammation‐Targeted and Antioxidative Poly(Ferulic Acid) Nanoparticles Directly Treat Chronic Nonbacterial Prostatitis via Inhibiting Pyroptosis by Disrupting Nrf2/KEAP1 Multimer Formation and as a Robust Drug Carrier
2025 · Bingliang Chen, Liying Wang, et al. · Advanced Healthcare Materials · 8
Evaluating the effectiveness of cytoreductive surgery in oligometastatic prostate cancer: insights from quantitative analysis and retrospective cohort studies
2024 · Bisheng Cheng, Bingheng Li, et al. · International Journal of Surgery · 8
Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathway
2020 · Kaiwen Li, Shirong Peng, et al. · Aging · 8
PDF
Discovering Novel P38α Inhibitors for the Treatment of Prostate Cancer Through Virtual Screening Methods
2019 · Kaiwen Li, Zean Li, et al. · Future Medicinal Chemistry · 8
PDF
Cancer Cell‐Intrinsic Cholesterol Induces Lipid‐Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer Progression
2026 · Shirong Peng, Weilong Lin, et al. · Advanced Science · 7
Hippocampal P2X4 receptor induces type 1 diabetes rats with neuropathic pain through microglial-derived neuroinflammation and neuronal damage
2025 · Xuanwei Zhang, Wenyu Zhang, et al. · Neuroscience · 7
Sorafenib Encapsulated Poly(ester amide) Nanoparticles for Efficient and Biosafe Prostate Cancer Therapy
2024 · Shunli Yu, Ruhe Zhang, et al. · ACS Biomaterials Science & Engineering · 7
PDHA1–acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer
2026 · Ruilin Zhuang, Qianghua Zhou, et al. · Cell Death and Disease · 4
PDF
Fuzheng–Buyi formula for treating castration-resistant prostate cancer: A systematic review and meta-analysis
2024 · Xiao Liang, Shirong Peng, et al. · Medicine · 3
Association between autoimmunity-related disorders and prostate cancer: A Mendelian randomization study
2024 · Peixian Chen, Yue Wang, et al. · Cancer Pathogenesis and Therapy · 3
Immune Signatures Combined With BRCA1-Associated Protein 1 Mutations Predict Prognosis and Immunotherapy Efficacy in Clear Cell Renal Cell Carcinoma
2021 · Ze Gao, Junxiu Chen, et al. · Frontiers in Cell and Developmental Biology · 2
The role of phosphatidylinositol (18:1_18:1) in benign prostatic hyperplasia: an integrated study of Mendelian randomization and network pharmacology
2025 · Bingliang Chen, Zhen He, et al. · World Journal of Urology
Works count: 30
Citation count: 432
H-index: 11
I10-index: 13
Year
Topic
Type